Lv3
226 积分 2025-09-16 加入
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors
3个月前
已完结
Preclinical development and a case report of a nanobody-based CLDN18.2 CAR-T IMC002 with reduced on-target off-tumor toxicity
3个月前
已完结
Versatile use of Carmofur: A comprehensive review of its chemistry and pharmacology
6个月前
已完结
PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer
10个月前
已完结
PBRM1, SETD2 and BAP1 — the trinity of 3p in clear cell renal cell carcinoma
11个月前
已完结
Clear cell renal cell carcinoma ontogeny and mechanisms of lethality
11个月前
已完结
皖公网安备34019202002308
